OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes
Nobuko Hijiya, Michael J. Mauro
Cancer Management and Research (2023) Vol. Volume 15, pp. 873-891
Open Access | Times Cited: 4
Nobuko Hijiya, Michael J. Mauro
Cancer Management and Research (2023) Vol. Volume 15, pp. 873-891
Open Access | Times Cited: 4
Showing 4 citing articles:
Current and future of targeted therapies against BCR::ABL kinases
Jayavel Sridhar, M. Subramanian, Pradeep Kumar Kesavan, et al.
Journal of the Egyptian National Cancer Institute (2025) Vol. 37, Iss. 1
Open Access
Jayavel Sridhar, M. Subramanian, Pradeep Kumar Kesavan, et al.
Journal of the Egyptian National Cancer Institute (2025) Vol. 37, Iss. 1
Open Access
Prevalence of medical writing in hematological malignancy review articles
Héctor Alejandro Vaquera Alfaro, Elham Nasrollahi, Yashvin Onkarappa Mangala, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Héctor Alejandro Vaquera Alfaro, Elham Nasrollahi, Yashvin Onkarappa Mangala, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Chronic myeloid leukemia with the e13a3 atypical fusion gene: A case report
Xin Zhou, Mengran Li, Ning‐ning Shan
Oncology Letters (2025) Vol. 29, Iss. 6, pp. 1-5
Open Access
Xin Zhou, Mengran Li, Ning‐ning Shan
Oncology Letters (2025) Vol. 29, Iss. 6, pp. 1-5
Open Access
Characterization of Asciminib-Resistant Philadelphia Chromosome-Positive Cells
Seiichi Okabe, Mitsuru Moriyama, Akihiko Gotoh
World Journal of Oncology (2024) Vol. 15, Iss. 2, pp. 319-324
Open Access | Times Cited: 2
Seiichi Okabe, Mitsuru Moriyama, Akihiko Gotoh
World Journal of Oncology (2024) Vol. 15, Iss. 2, pp. 319-324
Open Access | Times Cited: 2
Combination of an aurora kinase inhibitor and the ABL tyrosine kinase inhibitor asciminib against ABL inhibitor-resistant CML cells
Seiichi Okabe, Mitsuru Moriyama, Akihiko Gotoh
Medical Oncology (2024) Vol. 41, Iss. 6
Open Access | Times Cited: 1
Seiichi Okabe, Mitsuru Moriyama, Akihiko Gotoh
Medical Oncology (2024) Vol. 41, Iss. 6
Open Access | Times Cited: 1
